Abstract: From 1998 to 2001, using questionnaires, we surveyed the use of travel vaccines among Japanese expatriates in developing countries. The percentage of those using more than one type of travel vaccine before departure increased significantly (45.6% in 1998 to 53.4% in 2001 (p<0.001)). In regions such as tropical Africa and South Asia, vaccination rates were high. But the increase was most noticeable in East Asia, the Middle East, and Latin America. Vaccinations against hepatitis A, hepatitis B, and tetanus were high throughout the developing countries. Vaccinations against yellow fever and Japanese encephalitis were high in endemic regions. Vaccination rates were slightly higher for typhoid fever in South Asia and tropical Africa than that in other areas. Vaccination rates for cholera, however, showed yearly declines. These trends seem to reflect a growing awareness among expatriates of the benefits of travel vaccines. Even so, nearly half of those living the countries have not received sufficient vaccination, indicating a need for further education.
INTRODUCTION
Global business has resulted in an increase in the number of Japanese living abroad long-term. According to statistics from the Ministry of Foreign Affairs, the number of Japanese expatriates in 2002 was 590,000 people, approximately three times as many as in 1980. Of these, about 200,000 people live in developing countries, and are at risk of various local infectious diseases [1] .
In order to lower the risk of infectious diseases overseas, travel vaccine can be administered. However, vaccination rates tend to be low among Japanese expatriates. According to research by Basnyat from 1997 to 1998 in Katmandu, 95% of Japanese travelers were not vaccinated against hepatitis A or typhoid fever [2] . Among nonJapanese people, 90% had been vaccinated against these diseases. Therefore, we developed a questionnaire-based investigation to further clarify the situation.
METHODS
Each year, we perform a health consultation service for Japanese expatriates residing in urban areas of developing countries. The subjects of this survey were Japanese expa- triates who responded to the consultation from 1998 to 2001. The research was limited to those 16 years of age or older. Many of the subjects were employees sent from Japanese companies, and their families. From 1998 to 2001, during the consultation, questionnaires were given to the subjects. On the questionnaire, the travel vaccines were listed, and the subjects were requested to note the vaccines they had received before departure. Table 1 shows the number of responses corresponding to the year they were received.
The list contained the following 10 vaccines: hepatitis A, hepatitis B, tetanus, rabies, yellow fever, Japanese encephalitis, cholera, typhoid fever, and meningococcal meningitis.
We used the chi-square method to analyze the data.
RESULTS
(1) Total vaccination rate Table 2 shows the percentage of respondents who received one or more types of travel vaccine before departure. The vaccination rate elevated from 45.6% in 1998 to 53.4% by 2001. The value in 2001 is significantly higher than that in 1998 (p<0.001).
On a regional basis, in 1998, the vaccination rates in tropical Africa and South Asia were high and did not vary much during the period of this survey. On the other hand, in East Asia and the Middle East, the vaccination rate in 1998 was only about 30%. The subsequent years showed dramatic increases, and by 2001 both regions showed rates higher than 45%. In Latin America, the rate also rose from 44.7% in 1998 to 56.6% by 2001.
(2) Individual vaccines' vaccination rate
The vaccination rates of individual vaccines excluding cholera and meningococcal meningitis showed an increase from 1998 to 2001 (Table 3 ). In 2001, the rate for hepatitis A was the highest at 40.3%, hepatitis B and tetanus were in the 30% range, followed by rabies at 18.2%. The rate for cholera decreased, coming to 2.1% in 2001, and that for meningococcal meningitis did not change during the period.
All regions showed increases in rates for hepatitis A, hepatitis B, tetanus, and rabies (Table 4 ). In 2001, the rate for hepatitis A in tropical Africa was highest at 53.9% and lowest in the Middle East at 30.0%. The rate for hepatitis B was highest in tropical Africa at 50.6%, lowest in the Middle East at 22.7%. The rate for tetanus was highest in South Asia at 54.8% and lowest in East Asia at 22.5%. Rabies was highest in South Asia at 37.3% and lowest in East Asia at 3.9%.
For yellow fever, vaccination rates in endemic regions such as tropical Africa and Latin America were high. In tropical Africa, rates increased only slightly: from 79.1% in 1998 to 81.1% in 2001. In Latin America, rates increased more dramatically: from 15.2% in 1998 to 25.9% in 2001.
Vaccination rates were high for Japanese encephalitis In all regions, the vaccination rates for cholera decreased during the periods of this survey.
DISCUSSION
Infectious diseases are a major health issue for overseas tourists and expatriates in developing countries. For example, Steffen estimated that the infection rate for hepatitis A is 0.2% for people residing in a developing country for a month [1] . In an investigation by Ohara using members of Japan Overseas Cooperation Volunteers as subjects, the disease rate for1year reached 3. 9% in 1979 [3] . In a subsequent investigation using the same subjects in 1980, the rate for hepatitis B was 1.09% per year. There have been no cases of rabies among Japanese expatriates since 1970. However, according to an investigation by Takayama, from 1990 to 1996, the number of subjects who visited a metropolitan hospital for post-exposure vaccination of rabies rose to 93 cases [4] . According to a report by the National Institute of Infectious Diseases, 44 cases of typhoid fever and 25 cases of cholera were reported in 2000. There have been no reports of yellow fever among Japanese travelers, but there have been cases among European and American travelers in endemic regions [5] .
Travel vaccines are regarded as an effective means of preventing these diseases [6] . For travelers to developing countries, vaccination for hepatitis A, hepatitis B, tetanus, rabies, and typhoid fever are strongly recommended. Also, vaccinations are recommended for yellow fever in tropical Africa and South America and for Japanese encephalitis in Asia.
Since we know that the vaccination rate for Japanese travelers is extremely low [2], we conducted this survey on Japanese expatriates living in developing countries from 1998 to 2001. The results show that the percentage of people receiving one or more types of travel vaccine before departure increased from 45.6% in 1998 to 53.4% in 2001. The vaccination rates in tropical Africa and South Asia were high, but did not increase much from 1998 to 2001. On the other hand, the vaccination rates in East Asia and the Middle East, which had been low in 1998, increased dramatically, reaching over 45% by 2001.
Rates for individual vaccinations of hepatitis A, hepatitis B, and tetanus were high in all regions, while rates for yellow fever and Japanese encephalitis were high only in endemic regions.
During the period of this survey, vaccination rates of all vaccines excluding cholera and meningococcal meningitis increased. The rates of hepatitis A, hepatitis B, and tetanus dramatically increased in East Asia, the Middle East, and Latin America. The increase in rabies vaccination rate . Presently there is some doubt about the effectiveness of the cholera vaccine used in Japan, so it is possible that this caused the vaccination rates to decrease in all regions [7] . Vaccination rates for typhoid fever and meningococcal meningitis tended to be low on the whole. This was because these vaccines were not available in Japan [8] . But in 2001, the vaccination rate for typhoid fever in South Asia (10.9%) and tropical Africa (16.7%), and the rate for meningococcal meningitis in tropical Africa (20.6%) were higher than those in another areas. We assume that Japanese people living in highly endemic regions were able to find a way to receive vaccinations. For vaccines not marketed in Japan, it is still possible to receive a vaccination if a doctor privately imports the vaccines. We need to make this fact better known to Japanese medical personnel.
Looking at the overall picture, the increasing rates indicate a growing awareness among Japanese expatriates and medical personnel of the benefits of vaccination. However, nearly half of Japanese people residing in developing countries are not vaccinated. For short-term visitors, the vaccination rate is probably even lower. In a recent investigation by Kikuchi, which surveyed a Japanese tourist group visiting tropical Africa, the vaccination rate for yellow fever was high at 80% [9] . However, the rates of other vaccines such as hepatitis A and rabies were below 5%. An investigation on German tourists receiving hepatitis vaccine before going to developing countries showed a very high rate of 59% [10] .
In summary, it is clear that despite some improvement, vaccination rates are still alarmingly low among Japanese travelers. The solution to this problem is better education and knowledge transfer, both to the travelers who should receive these vaccines, and to the medical personnel who consult with travelers and administer vaccinations.
